Oxygenta Pharmaceutical (BOM:524636) Cyclically Adjusted PB Ratio: (As of Sep. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524636 Oxygenta Pharmaceutical Ltd BOM:524636
57 GF Score
Price ₹52.76
GF Value ₹85.47
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Oxygenta Pharmaceutical Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Oxygenta Pharmaceutical  (BOM:524636) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Oxygenta Pharmaceutical Cyclically Adjusted PB Ratio Related Terms


Oxygenta Pharmaceutical Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Oxygenta Pharmaceutical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxygenta Pharmaceutical Cyclically Adjusted PB Ratio Chart

Oxygenta Pharmaceutical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Oxygenta Pharmaceutical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BOM:524636 vs ZTS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Oxygenta Pharmaceutical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxygenta Pharmaceutical Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Oxygenta Pharmaceutical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Oxygenta Pharmaceutical's Cyclically Adjusted PB Ratio falls into.


BOM:524636
57GF Score
Oxygenta Pharmaceutical Ltd BOM:524636
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oxygenta Pharmaceutical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Oxygenta Pharmaceutical's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Oxygenta Pharmaceutical's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=/167.3573*167.3573
=0.000

Current CPI (Jun. 2026) = 167.3573.

Oxygenta Pharmaceutical Quarterly Data

Book Value per Share CPI Adj_Book
201609 -23.345 105.961 -36.872
201612 0.000 105.196 0.000
201703 -26.838 105.196 -42.697
201706 0.000 107.109 0.000
201709 -28.799 109.021 -44.209
201712 0.000 109.404 0.000
201803 -31.277 109.786 -47.678
201806 0.000 111.317 0.000
201809 -31.492 115.142 -45.773
201812 0.000 115.142 0.000
201903 -34.467 118.202 -48.800
201906 0.000 120.880 0.000
201909 -37.684 123.175 -51.201
201912 0.000 126.235 0.000
202003 -40.140 124.705 -53.869
202006 0.000 127.000 0.000
202009 -40.904 130.118 -52.611
202012 0.000 130.889 0.000
202103 -37.268 131.771 -47.333
202106 0.000 134.084 0.000
202109 -23.894 135.847 -29.436
202112 0.000 138.161 0.000
202203 -24.384 138.822 -29.396
202206 0.000 142.347 0.000
202209 -27.222 144.661 -31.493
202212 0.000 145.763 0.000
202303 -32.532 146.865 -37.071
202306 0.000 150.280 0.000
202309 -7.297 151.492 -8.061
202312 0.000 152.924 0.000
202403 -6.010 153.035 -6.572
202406 0.000 155.789 0.000
202409 -5.958 157.882 -6.316
202412 0.000 158.323 0.000
202503 -6.933 157.552 -7.364
202506 0.000 159.755 0.000
202509 -9.918 162.289 -10.228
202512 0.000 163.281 0.000
202603 -11.542 164.272 -11.759
202606 0.000 167.357 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Oxygenta Pharmaceutical (BOM:524636) Overvalued in 2026?

Based on GuruFocus' analysis, Oxygenta Pharmaceutical stock appears to be undervalued. The current stock price of ₹52.76 is trading 38.3% below its estimated GF Value™ of ₹85.47. GuruFocus considers Oxygenta Pharmaceutical to be Possible Value Trap.

Key valuation signals for BOM:524636:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: ₹85.47 vs. price of ₹52.76 (38.3% below fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the BOM:524636 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Oxygenta Pharmaceutical Business Description

Address Plot No. B1 & B2, IDA Gandhi Nagar, Kukatpally, Hyderabad, TG, IND, 500037
Oxygenta Pharmaceutical Ltd is a pharmaceutical company. It is engaged in the business activity of is engaged in manufacturing and selling of Pharmaceutical, medical, and veterinary preparations. The Company has one reportable segment, which is Pharmaceutical. The group carries out its business operations within India.
57GF Score

Get the complete analysis for BOM:524636

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹52.76
Price
₹85.47
GF Value